Subcutaneous Interval Lengthening of Vedolizumab for Economic Research
Clinical trial NCT06584162 · RECRUITING
Trial details
- NCT number
- NCT06584162
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-09
- Primary completion
- 2025-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.